Option chain shows key data for SILO Pharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for SILO Pharma.

SILO Pharma (NASDAQ:SILO) Stock, Option Chain

SILO Pharma

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Display,Of,Stock,Market,Quotes

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

CRCL

DTCK

ELAB

HSDT

KLTO

LIMN

MTSR

NAMM

Nuveen Insured California Premium Fund Ii

NOVA

OPEN

PLCE

PYPD

SATS

SILO

Tempest Therapeutics, Inc. - Common Stock

TPST

Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Wall Street

Equities

$BTC

CERO

DOCU

INAB

IONQ

MPAA

TSLA

U.S. stock futures were flat on Monday after closing higher on Friday. Futures of major benchmark indices were mixed in premarket.

US Stocks Likely To Open On A Mixed Note After S&amp;P 500 Scales 6,000-Mark: &#39;Whole Globe Is In A Bull Market&#39;

mongoDB

BARK

CBUS

CHPT

CTNT

KAPA

MBIO

MCTR

MKDW

MULN

NYXH

VRNT

Why MongoDB Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

SILO Pharma Inc

Silo Wellness Inc

Press Releases

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Health Care

Legal

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study  for our Novel Intranasal PTSD Therapy, SPC-15

Silo Pharma Announces Pricing of $2 Million Public Offering

Silo Pharma Announces Closing of $2 Million Public Offering

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Aptevo Therapeutics

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

Azitra

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Ensysce Biosciences

Galecto

GRI Bio

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Mustang Bio

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Oragenics

Palisade Bio

Polyrizon

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Synaptogenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Tharimmune

Theriva Biologics

VivoSim Labs

Xenetic Biosciences

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics

Laidlaw & Co.

Screenshot 2024-05-21 at 6.46.56 PM

Biotech

General

ATAI

FTRP

Revolutionizing Mental Healthcare With The Rise Of Ketamine And Psychedelic Therapies

Comments

SILO Pharma

SILO Pharma (SILO) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell